9/8/2025

Bristol-Myers Squibb’s strong oncology sales and upcoming approvals make its stock’s risk/reward profile increasingly attractive. Read more here on BMY stock here.

Source: SeekingAlpha

9/6/2025

BioNTech's Phase 3 breast cancer data supports its oncology shift, but global impact is limited and competition remains fierce. Find out why BNTX stock is a hold.

Source: SeekingAlpha

9/5/2025

Pfizer Inc.'s strong Q2 2025 sales defy expectations. Discover analyst insights, growth drivers, and why it's rated Strong Buy. Click for my PFE stock update.

Source: SeekingAlpha

9/1/2025

Biotech is entering a new growth cycle driven by AI and CRISPR innovation, but current ETF valuations are high and volatility is elevated.

Source: SeekingAlpha

8/31/2025

Large-cap biotechs are a potential new asset class as China and D.C. pressure Big Pharma to invest elsewhere.

Source: Yahoo

8/31/2025

Pfizer Inc. (NYSE:PFE) is one of the top most undervalued low volatility stocks to buy now. Pfizer Inc. (NYSE:PFE) announced on August 27 the US Food and Drug Administration’s (FDA) approval of the supplemental Biologics License Application (sBLA) for the companies’ LP.8.1-adapted monovalent COVID-19 vaccine (COMIRNATY® LP.8.1; COVID-19 Vaccine, mRNA). The vaccine is to be […]

Source: Yahoo

8/28/2025

According to DataM Intelligence, the global oncology therapy market size reached US$ 193.98 billion in 2024 and is expected to reach US$ 440.26 billion by 2033, growing at a CAGR of 9.6% during the forecast period 2025-2033.

Source: Yahoo

8/28/2025

Moderna and Pfizer/BioNTech have secured formula updates to existing mRNA Covid-19 vaccines.

Source: Yahoo

8/28/2025

We recently published 11 Best Cancer Stocks to Buy Right Now. BioNTech SE is one of them. BioNTech SE (NASDAQ:BNTX), a German biotechnology company, specializes in mRNA-based immunotherapies for cancer and infectious diseases and stands eleventh on our list among the best cancer stocks. Following its global recognition for the COVID-19 vaccine, the company has been […]

Source: Yahoo

8/28/2025

mRNA vaccine stocks face challenges post-pandemic. Discover why 'pick-and-shovel' biotech suppliers may offer better investment stability and growth.

Source: SeekingAlpha

8/27/2025

BioNTech stock skidded Wednesday after the Food and Drug Administration ended its broad authorization of Covid vaccines in the U.S.

Source: Yahoo

8/27/2025

Health care stocks were mixed late Wednesday afternoon, with the NYSE Health Care Index adding 0.1%

Source: Yahoo

8/27/2025

Health care stocks rose Wednesday afternoon with the NYSE Health Care Index adding 0.2% and the Heal

Source: Yahoo

8/27/2025

The Food and Drug Administration approved shots from Pfizer, Moderna and Novavax, but for a narrower population.

Source: Yahoo

8/27/2025

The 2025-2026 COVID-19 vaccine formulation targets the SARS-CoV-2 sublineage LP.8.1, in line with FDA guidance to more closely match circulating strains1Shipping of the LP.8.1-adapted vaccine will begin immediately to ensure robust supply and rapid access of this season’s vaccine in pharmacies, hospitals, and clinics across the country NEW YORK and MAINZ, GERMANY, AUGUST 27, 2025 — Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced the U.S. Food and Drug

Source: Yahoo

8/27/2025

European equities traded in the US as American depositary receipts were trending lower late Wednesda

Source: Yahoo

8/27/2025

clock.bio, the rejuvenation biology company developing therapies to reverse aging and extend healthspan, today announced the appointment of Dr. Michael Boehler, former BioNTech executive, as Chief Business Officer. Dr. Boehler will lead the company's business development, strategic partnerships, and commercialization efforts, working closely with the leadership team to advance clock.bio's breakthrough rejuvenation biology platform.

Source: Yahoo

8/27/2025

The Trump administration is preparing to remove COVID-19 vaccines from the U.S. market "within months," according to a close associate of Health and Human Services Secretary Robert F. Kennedy Jr. Shortly after the update, COVID-19 vaccine stocks, ...

Source: Yahoo

8/25/2025

European equities traded in the US as American depositary receipts opened the week marginally lower

Source: Yahoo

8/19/2025

BioNTech (BNTX) recently experienced a 10% price increase in the last quarter, coinciding with the Health Canada's authorization of its variant-adapted COMIRNATY COVID-19 vaccine, a potential positive catalyst. During this period, BioNTech also benefited from positive updates such as the European Medicines Agency's recommendation for its COVID-19 vaccine and the narrowing of net losses reported in Q2, reinforcing investor confidence. Meanwhile, broader market trends showed a general rise,...

Source: Yahoo